Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators

Journal of Medicinal Chemistry
T A GreseH U Bryant

Abstract

The 2-arylbenzothiophene raloxifene, 1, is a selective estrogen receptor modulator (SERM) which is currently under clinical evaluation for the prevention and treatment of postmenopausal osteoporosis. In vivo structure-activity relationships and molecular modeling studies have indicated that the orientation of the basic amine-containing side chain of 1, relative to the stilbene plane, is an important discriminating factor for the maintenance of tissue selectivity. We have constructed a series of analogues of 1 in which this side chain is held in an orientation which is orthogonal to the stilbene plane, similar to the low-energy conformation predicted for raloxifene. Herein, we report on the synthesis of these compounds and on their activity in a series of in vitro and in vivo biological assays reflective of the SERM profile. In particular, we describe their ability to (1) bind the estrogen receptor, (2) antagonize estrogen-stimulated proliferation of MCF-7 cells in vitro, (3) stimulate TGF-beta3 gene expression in cell culture, (4) inhibit the uterine effects of ethynyl estradiol in immature rats, and (5) potently reduce serum cholesterol and protect against osteopenia in ovariectomized (OVX) rats without estrogen-like stimulati...Continue Reading

References

Jun 15, 1995·The New England Journal of Medicine·G A ColditzF E Speizer
Jun 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M SatoH U Bryant
Oct 24, 1997·Nature·A M BrzozowskiM Carlquist
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·T A GreseJ A Dodge

❮ Previous
Next ❯

Citations

Dec 13, 2006·Cancer Metastasis Reviews·Muzaffer Cicek, Merry Jo Oursler
Dec 4, 2003·Bioorganic & Medicinal Chemistry Letters·Nobuhide WatanabeJun-ichi Tsuji
Feb 26, 2004·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Apr 28, 2004·Bioorganic & Medicinal Chemistry Letters·Helen Y ChenMilton L Hammond
Jun 14, 2005·Molecular and Cellular Endocrinology·Sanjay KansraNira Ben-Jonathan
Jun 8, 2001·Bioorganic & Medicinal Chemistry Letters·R TedescoJ A Katzenellenbogen
Feb 5, 2003·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
May 17, 2003·Bioorganic & Medicinal Chemistry Letters·Owen B WallaceJeffrey A Dodge
May 18, 1999·Bioorganic & Medicinal Chemistry Letters·C R SchmidG A Stephenson
Feb 24, 2001·Bioorganic & Medicinal Chemistry·S R StaufferJ A Katzenellenbogen
Mar 12, 2003·Bioorganic & Medicinal Chemistry·Jonathan M SchmidtPeter R Redden
Aug 7, 2003·Bioorganic & Medicinal Chemistry·Kyo Chul LeeDae Yoon Chi
Feb 1, 2012·Journal of Chemical Information and Modeling·Ying-Ting Lin, Guan-Yu Chen
Aug 2, 2007·Chemical Communications : Chem Comm·Gang Cheng, Youhong Hu
Jun 29, 2000·Annual Review of Biochemistry·R V WeathermanT S Scanlan
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·L A PaigeD M Fowlkes
Mar 1, 2006·Expert Opinion on Investigational Drugs·Pamela N Munster
Oct 27, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Danyetta D DavisRobert W Brueggemeier
Oct 15, 2013·Chemical Biology & Drug Design·Vivian I BonanoSilvia R B Uliana
Jun 19, 2010·CNS Neuroscience & Therapeutics·Maria Gabriela SánchezThérèse Di Paolo
May 18, 2000·Cancer Treatment Reviews·E A Lien, P E Lønning
Jun 19, 2004·Bioorganic & Medicinal Chemistry Letters·Qiang TanMilton L Hammond
Jun 19, 2004·Bioorganic & Medicinal Chemistry Letters·Qiang TanMilton L Hammond
Aug 15, 2017·Organic & Biomolecular Chemistry·Jorgelina L PergometTeodoro S Kaufman
Jun 27, 2018·Menopause : the Journal of the North American Menopause Society·Dongfeng ZhaoBing Shu
Dec 15, 2006·American Journal of Physiology. Cell Physiology·Gennadi M KravtsovTak Ming Wong
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C K OsborneS A Fuqua
Dec 17, 2008·Organic & Biomolecular Chemistry·Sonsoles Martín-SantamaríaAna Ramos
May 29, 2008·The Journal of Organic Chemistry·Gang Cheng, Youhong Hu
Oct 9, 2007·Journal of Medicinal Chemistry·Andrew J S KnoxDavid G Lloyd
Nov 13, 2004·Journal of Medicinal Chemistry·Dennis R ComptonJohn A Katzenellenbogen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.